Trial intelligence / Profile preview

Propranolol Gel in Infants With Infantile Hemangioma

NCT01512173Phase 2Completed

Sponsor
Pierre Fabre Laboratories
Start
Jan 2012
Primary completion
May 2013
Modality
Small Molecules
Countries
3
01

Overview

A Phase 2 trial of propranolol in infantile hemangioma (IH), sponsored by Pierre Fabre Laboratories. Started Jan 2012; status: completed.

02

Drugs

propranolol
03

Conditions

infantile hemangioma (IH)

Beyond the preview

Go deeper on NCT01512173.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01512173.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call